Wondering if tirzepatide comes in a pill? Here's what you need to know about the injectable form currently available and the future of oral tirzepatide.
If you've been looking into tirzepatide for managing type 2 diabetes or weight loss, you might have stumbled across questions about whether a pill version exists. It's a fair question, and one that comes up a lot on the MounjaBlog community. The short answer? Right now, tirzepatide is only available as a subcutaneous injection, sold under the brand name Mounjaro for diabetes and Zepbound for weight loss. There is no oral tablet form of tirzepatide approved or available at this time.
But the story doesn't end there. Pharmaceutical research is always moving, and understanding the difference between what's available now and what might come next helps you have smarter conversations with your doctor.
What Is Tirzepatide and How Does It Work?
Tirzepatide is a dual GIP and GLP-1 receptor agonist. That means it mimics two natural hormones in your body that help regulate blood sugar and appetite. Approved by the FDA in 2022 for type 2 diabetes and in 2023 for chronic weight management, tirzepatide works by slowing stomach emptying, helping you feel fuller longer, and encouraging your pancreas to release the right amount of insulin after meals.
Currently, tirzepatide is administered as a weekly subcutaneous injection. Patients use a pre-filled pen and inject it under the skin of the stomach, thigh, or upper arm. The dosing starts low and gradually increases over several weeks to help your body adjust and reduce the chance of side effects.
Is There an Oral Version of Tirzepatide?
No oral version of tirzepatide exists today. Unlike semaglutide, which is available as both an oral tablet (Rybelsus) and an injectable (Ozempic, Wegovy), tirzepatide has only been developed and approved in injectable form so far.
Eli Lilly, the manufacturer of tirzepatide, has conducted and continues to conduct research on oral formulations, but nothing has reached regulatory approval yet. Any claims you see online about an oral tirzepatide pill being available should be treated with caution, as they likely refer to a different medication entirely.
What About Oral Medications in the Same Drug Class?
If an oral option interests you, it's worth knowing that the GLP-1 medication class does include oral alternatives. Semaglutide, for example, is available as Rybelsus, a daily oral tablet for type 2 diabetes. Oral semaglutide works on the same GLP-1 pathway that tirzepatide targets, though tirzepatide also activates the GIP receptor.
Eli Lilly has also been developing an oral GLP-1 medication called orforglipron. This is a separate molecule from tirzepatide and is taken as a daily pill. Clinical trials for orforglipron are underway, with Eli Lilly announcing in March 2024 that the program had advanced to Phase 3 studies, but it is not yet approved by the FDA. It is not the same as oral tirzepatide.
The reason creating an oral version of tirzepatide is particularly challenging has to do with its molecular structure. Tirzepatide is a large peptide, which means your digestive system would break it down before it could be absorbed if taken as a pill. This is why injectable administration has been the only effective route so far.
Why the Injection Format Matters
For many people, the idea of a weekly injection sounds less convenient than swallowing a pill. But injectable tirzepatide actually offers some advantages. The weekly dosing means you only need to think about it once every seven days. The injection bypasses the digestive tract entirely, which ensures the medication enters your bloodstream reliably and consistently.
Studies have shown that tirzepatide injection can produce significant improvements in HbA1c levels and body weight reduction. Patients on the highest approved dose in clinical trials saw average HbA1c reductions of over 2 percentage points and substantial weight loss over 72 weeks.
The injection itself uses a very thin needle, similar to an insulin pen. Most people describe it as barely noticeable. You can inject it at any time of day, with or without food, which adds flexibility.
What Could the Future Look Like?
Research into oral peptides is an active area of pharmaceutical science. Scientists are exploring different technologies, including absorption enhancers and special coatings, to help peptide drugs survive the digestive system. While some of these approaches show promise, none have yet produced an FDA-approved oral version of tirzepatide.
Until an oral option receives approval, tirzepatide remains injectable. If you have a strong preference for oral medications, discussing all available options with your healthcare provider is the best step. They can help you weigh the benefits and drawbacks of each medication based on your health profile, preferences, and goals.
For now, injectable tirzepatide remains one of the most effective medications available for both type 2 diabetes management and weight loss. The MounjaBlog team keeps an eye on emerging research so you can stay informed as things develop.
FAQ
Can I take tirzepatide as a pill instead of an injection?
No. Tirzepatide is currently only available as a weekly subcutaneous injection. There is no approved oral tablet form.
Is there any oral medication similar to tirzepatide?
Semaglutide has an oral form called Rybelsus, which is a daily tablet for type 2 diabetes. It works on the GLP-1 pathway but does not activate the GIP receptor the way tirzepatide does.
What is the difference between Mounjaro and Zepbound?
They are the same medication (tirzepatide) marketed under different brand names. Mounjaro is approved for type 2 diabetes, while Zepbound is approved for chronic weight management in adults with obesity or overweight with at least one weight-related condition.
Does Eli Lilly plan to release an oral version of tirzepatide?
Eli Lilly has researched and continues to research oral formulations of tirzepatide, but none have received regulatory approval as of now. Their oral GLP-1 candidate orforglipron is a separate medication still under investigation in Phase 3 clinical trials.
How often do I inject tirzepatide?
Tirzepatide is injected once weekly, on the same day each week. You can take it at any time of day, with or without food, and you may change the day of the week if needed, as long as it has been at least three days since your last dose.
Sources
Disclaimer: This content is for informational purposes only and does not replace professional medical advice. Always consult your doctor before starting, changing or stopping any treatment.
Ozempro — Monitor GLP-1
Never miss a dose and track everything
Injection reminders, a dose history and a side-effects diary — all organized to bring to your appointment.
or download the app
